FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200097730> ?p ?o ?g. }

• W4200097730 endingPage "7513" @default.
• W4200097730 startingPage "7513" @default.
• W4200097730 abstract "Background: Radionuclides emitting Auger electrons (AEs) with low (0.02–50 keV) energy, short (0.0007–40 µm) range, and high (1–10 keV/µm) linear energy transfer may have an important role in the targeted radionuclide therapy of metastatic and disseminated disease. Erbium-165 is a pure AE-emitting radionuclide that is chemically matched to clinical therapeutic radionuclide 177Lu, making it a useful tool for fundamental studies on the biological effects of AEs. This work develops new biomedical cyclotron irradiation and radiochemical isolation methods to produce 165Er suitable for targeted radionuclide therapeutic studies and characterizes a new such agent targeting prostate-specific membrane antigen. Methods: Biomedical cyclotrons proton-irradiated spot-welded Ho(m) targets to produce 165Er, which was isolated via cation exchange chromatography (AG 50W-X8, 200–400 mesh, 20 mL) using alpha-hydroxyisobutyrate (70 mM, pH 4.7) followed by LN2 (20–50 µm, 1.3 mL) and bDGA (50–100 µm, 0.2 mL) extraction chromatography. The purified 165Er was radiolabeled with standard radiometal chelators and used to produce and characterize a new AE-emitting radiopharmaceutical, [165Er]PSMA-617. Results: Irradiation of 80–180 mg natHo targets with 40 µA of 11–12.5 MeV protons produced 165Er at 20–30 MBq·µA−1·h−1. The 4.9 ± 0.7 h radiochemical isolation yielded 165Er in 0.01 M HCl (400 µL) with decay-corrected (DC) yield of 64 ± 2% and a Ho/165Er separation factor of (2.8 ± 1.1) · 105. Radiolabeling experiments synthesized [165Er]PSMA-617 at DC molar activities of 37–130 GBq·µmol−1. Conclusions: A 2 h biomedical cyclotron irradiation and 5 h radiochemical separation produced GBq-scale 165Er suitable for producing radiopharmaceuticals at molar activities satisfactory for investigations of targeted radionuclide therapeutics. This will enable fundamental radiation biology experiments of pure AE-emitting therapeutic radiopharmaceuticals such as [165Er]PSMA-617, which will be used to understand the impact of AEs in PSMA-targeted radionuclide therapy of prostate cancer." @default.
• W4200097730 created "2021-12-31" @default.
• W4200097730 creator A5020946838 @default.
• W4200097730 creator A5033107834 @default.
• W4200097730 creator A5043905644 @default.
• W4200097730 creator A5053858827 @default.
• W4200097730 creator A5055473242 @default.
• W4200097730 creator A5073167992 @default.
• W4200097730 creator A5081460346 @default.
• W4200097730 creator A5086906565 @default.
• W4200097730 date "2021-12-11" @default.
• W4200097730 modified "2023-09-27" @default.
• W4200097730 title "A High Separation Factor for 165Er from Ho for Targeted Radionuclide Therapy" @default.
• W4200097730 cites W1226786859 @default.
• W4200097730 cites W1964775136 @default.
• W4200097730 cites W1969944755 @default.
• W4200097730 cites W1982381330 @default.
• W4200097730 cites W1997023980 @default.
• W4200097730 cites W1998170068 @default.
• W4200097730 cites W2007306805 @default.
• W4200097730 cites W2010451867 @default.
• W4200097730 cites W2027180413 @default.
• W4200097730 cites W2031586165 @default.
• W4200097730 cites W2032269296 @default.
• W4200097730 cites W2039820494 @default.
• W4200097730 cites W2044603294 @default.
• W4200097730 cites W2046938652 @default.
• W4200097730 cites W2048140935 @default.
• W4200097730 cites W2053976911 @default.
• W4200097730 cites W2057603788 @default.
• W4200097730 cites W2071013806 @default.
• W4200097730 cites W2075101920 @default.
• W4200097730 cites W2076050948 @default.
• W4200097730 cites W2078925099 @default.
• W4200097730 cites W2090631269 @default.
• W4200097730 cites W2148113725 @default.
• W4200097730 cites W2166764562 @default.
• W4200097730 cites W2171312961 @default.
• W4200097730 cites W2320616831 @default.
• W4200097730 cites W2341926107 @default.
• W4200097730 cites W2416734619 @default.
• W4200097730 cites W2463368721 @default.
• W4200097730 cites W2473078107 @default.
• W4200097730 cites W2500017188 @default.
• W4200097730 cites W2531773505 @default.
• W4200097730 cites W2573369749 @default.
• W4200097730 cites W2578311142 @default.
• W4200097730 cites W2582967729 @default.
• W4200097730 cites W2759605227 @default.
• W4200097730 cites W2803965047 @default.
• W4200097730 cites W2886413864 @default.
• W4200097730 cites W2891407885 @default.
• W4200097730 cites W2907372863 @default.
• W4200097730 cites W2947948130 @default.
• W4200097730 cites W2960982763 @default.
• W4200097730 cites W2962774434 @default.
• W4200097730 cites W2965362447 @default.
• W4200097730 cites W2970375764 @default.
• W4200097730 cites W2979722259 @default.
• W4200097730 cites W3006006998 @default.
• W4200097730 cites W3011004682 @default.
• W4200097730 cites W3130934287 @default.
• W4200097730 cites W3139483172 @default.
• W4200097730 cites W4242599041 @default.
• W4200097730 doi "https://doi.org/10.3390/molecules26247513" @default.
• W4200097730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34946596" @default.
• W4200097730 hasPublicationYear "2021" @default.
• W4200097730 type Work @default.
• W4200097730 citedByCount "1" @default.
• W4200097730 countsByYear W42000977302023 @default.
• W4200097730 crossrefType "journal-article" @default.
• W4200097730 hasAuthorship W4200097730A5020946838 @default.
• W4200097730 hasAuthorship W4200097730A5033107834 @default.
• W4200097730 hasAuthorship W4200097730A5043905644 @default.
• W4200097730 hasAuthorship W4200097730A5053858827 @default.
• W4200097730 hasAuthorship W4200097730A5055473242 @default.
• W4200097730 hasAuthorship W4200097730A5073167992 @default.
• W4200097730 hasAuthorship W4200097730A5081460346 @default.
• W4200097730 hasAuthorship W4200097730A5086906565 @default.
• W4200097730 hasBestOaLocation W42000977301 @default.
• W4200097730 hasConcept C111337013 @default.
• W4200097730 hasConcept C121332964 @default.
• W4200097730 hasConcept C158973077 @default.
• W4200097730 hasConcept C177322064 @default.
• W4200097730 hasConcept C185544564 @default.
• W4200097730 hasConcept C185592680 @default.
• W4200097730 hasConcept C2989005 @default.
• W4200097730 hasConcept C2993559085 @default.
• W4200097730 hasConcept C62520636 @default.
• W4200097730 hasConcept C71924100 @default.
• W4200097730 hasConceptScore W4200097730C111337013 @default.
• W4200097730 hasConceptScore W4200097730C121332964 @default.
• W4200097730 hasConceptScore W4200097730C158973077 @default.
• W4200097730 hasConceptScore W4200097730C177322064 @default.
• W4200097730 hasConceptScore W4200097730C185544564 @default.
• W4200097730 hasConceptScore W4200097730C185592680 @default.
• W4200097730 hasConceptScore W4200097730C2989005 @default.
• W4200097730 hasConceptScore W4200097730C2993559085 @default.

• next